|
|
UCP3基因新突变致非综合征性肥胖的特征分析
|
Abstract:
目的：单基因非综合征性肥胖(MNSO)是一类独立于环境因素并由单一基因突变引起的个体肥胖，明确其病因与临床特征具有重要意义。方法：患者因腰椎间盘突出在我科住院治疗，收集病史及各项检查结果，因高度肥胖行全外显子组测序，明确病因并对致病基因突变进行生物信息学分析。结果：患者自10岁开始体重明显增加，入院时体重指数(BMI) 39.81，同时合并糖尿病与高血压，经基因检测在UCP3基因的3号外显子上发现变异(c.208C>T, p.R70W)，导致UCP3蛋白的第70个氨基酸Arg被Trp替代。Mutation Taster和Revel软件均预测该基因变异具有致病性。蛋白质3D模型显示突变主要发生在缬氨酸(Val)和精氨酸(Arg)，而且UCP3基因突变还可以增加2型糖尿病的发病风险。结论：UCP3基因突变是单基因非综合征性肥胖和2型糖尿病重要遗传因素。
Objective: Monogenic non-syndromic obesity (MNSO) is a type of individual obesity that is inde-pendent of environmental factors and caused by a single gene mutation. It is of great significance to clarify its etiology and clinical characteristics. Methods: The patients were hospitalized in our de-partment due to lumbar disc herniation. The medical history and various examination results were collected. The whole Exon group was sequenced due to high obesity. The etiology was identified and the pathogenic gene mutation was analyzed by bioinformatics. Results: The patient’s weight in-creased significantly since he was 10 years old. At admission, his body mass index (BMI) was 39.81. At the same time, he was complicated with diabetes and hypertension. Through Genetic testing, a mutation was found in exon 3 of UCP3 gene (c.208C>T, p.R70W), resulting in the replacement of Arg, the 70th amino acid of UCP3 protein, by Trp. Mutation Taster and Revel software both predict the pathogenicity of this gene variant. The protein 3D model showed that mutations mainly occurred in Valine (Val) and arginine (Arg), and UCP3 gene mutations could also increase the risk of type 2 dia-betes. Conclusions: Mutation of UCP3 is an important genetic factor for monogenic non-syndromic obesity and type 2 diabetes.
| [1] | Fontaine, K.R., Redden, D.T., Wang, C., et al. (2003) Years of Life Lost Due to Obesity. JAMA, 289, 187-193.
https://doi.org/10.1001/jama.289.2.187 |
| [2] | (2000) Obesity: Preventing and Managing the Global Epidemic. Report of a WHO Consultation. World Health Organization Technical Report Series, 894, 1-253. |
| [3] | Loos, R.J.F. and Yeo, G.S.H. (2022) The Genetics of Obesity: From Discovery to Biology. Nature Reviews Genetics, 23, 120-133. https://doi.org/10.1038/s41576-021-00414-z |
| [4] | Peeters, A., Barendregt, J.J., Willekens, F., et al. (2003) Obesity in Adulthood and Its Consequences for Life Expectancy: A Life-Table Analysis. Annals of Internal Medicine, 138, 24-32.
https://doi.org/10.7326/0003-4819-138-1-200301070-00008 |
| [5] | Pigeyre, M., Yazdi, F.T., Kaur, Y. and Meyre, D. (2016) Recent Progress in Genetics, Epigenetics and Metagenomics Unveils the Pathophysiology of Human Obesity. Clinical Science, 130, 943-986. https://doi.org/10.1042/CS20160136 |
| [6] | Xia, Q. and Grant, S.F. (2013) The Ge-netics of Human Obesity. Annals of the New York Academy of Sciences, 1281, 178-190. https://doi.org/10.1111/nyas.12020 |
| [7] | Mahmoud, R., Kimonis, V. and Butler, M.G. (2022) Genetics of Obesity in Humans: A Clinical Review. International Journal of Molecular Sciences, 23, Article 11005. https://doi.org/10.3390/ijms231911005 |
| [8] | WHO (2020) WHO Obesity and Overweight. WHO. |
| [9] | WHO (2018) WHO The Top 10 Causes of Death. WHO. |
| [10] | Oussaada, S.M., van Galen, K.A., Cooiman, M.I., et al. (2019) The Pathogenesis of Obesity. Metabolism, 92, 26-36.
https://doi.org/10.1016/j.metabol.2018.12.012 |
| [11] | Bray, G.A., Kim, K.K., Wilding, J.P.H., on Behalf of the World Obesity Federation (2017) Obesity: A Chronic Relapsing Progressive Disease Process. A Position Statement of the World Obesity Federation. Obesity Reviews, 18, 715-723. https://doi.org/10.1111/obr.12551 |
| [12] | Kleinendorst, L., Massink, M.P.G., Cooiman, M.I., et al. (2018) Genetic Obesity: Next-Generation Sequencing Results of 1230 Patients with Obesity. Journal of Medical Genetics, 55, 578-586.
https://doi.org/10.1136/jmedgenet-2018-105315 |
| [13] | Bell, C.G., Walley A.J. and Froguel, P. (2005) The Genetics of Human Obesity. Nature Reviews Genetics, 6, 221-234.
https://doi.org/10.1038/nrg1556 |
| [14] | Nordang, G.B.N., Busk, ？.L., Tveten, K., et al. (2017) Next-Generation Se-quencing of the Monogenic Obesity Genes LEP, LEPR, MC4R, PCSK1 and POMC in a Norwegian Cohort of Patients with Morbid Obesity and Normal Weight Controls. Molecular Genetics and Metabolism, 121, 51-56. https://doi.org/10.1016/j.ymgme.2017.03.007 |
| [15] | Saeed, S., Bonnefond, A., Manzoor, J., et al. (2015) Genetic Variants in LEP, LEPR and MC4R Explain 30% of Severe Obesity in Children from a Consanguineous Population. Obe-sity, 23, 1687-1695. https://doi.org/10.1002/oby.21142 |
| [16] | Ak？nc？, A., Türkkahraman, D., Tekedereli, ？., et al. (2019) Novel Mutations in Obesity-Related Genes in Turkish Children with Non-Syndromic Early Onset Severe Obesity: A Multicentre Study. Journal of Clinical Research in Pediatric Endocrinology, 11, 341-349. https://doi.org/10.4274/jcrpe.galenos.2019.2019.0021 |
| [17] | Hill, J.O., Wyatt, H.R. and Peters, J.C. (2012) Energy Balance and Obesity. Circulation, 126, 126-132.
https://doi.org/10.1161/CIRCULATIONAHA.111.087213 |
| [18] | Paolacci, S., Pompucci, G., Paolini, B., et al. (2019) Mendelian Non-Syndromic Obesity. Acta Biomedica Atenei Parmensis, 90, 87-89. |
| [19] | Crowley, V.E. (2008) Overview of Human Obesity and Central Mechanisms Regulating Energy Homeostasis. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine, 45, 245-255.
https://doi.org/10.1258/acb.2007.007193 |
| [20] | Farooqi, I.S. and O’Rahilly, S. (2008) Mutations in Ligands and Receptors of the Leptin-Melanocortin Pathway that Lead to Obesity. Nature Clinical Practice Endocrinology & Metabo-lism, 4, 569-577.
https://doi.org/10.1038/ncpendmet0966 |
| [21] | Farooqi, S. and O’Rahilly, S. (2006) Genetics of Obesity in Humans. Endocrine Reviews, 27, 710-718.
https://doi.org/10.1210/er.2006-0040 |
| [22] | Mutch, D.M. and Clément, K. (2006) Unraveling the Genetics of Human Obesity. PLOS Genetics, 2, e188.
https://doi.org/10.1371/journal.pgen.0020188 |
| [23] | Musa, C.V., Mancini, A., Alfieri, A., et al. (2012) Four Novel UCP3 Gene Variants Associated with Childhood Obesity: Effect on Fatty Acid Oxidation and on Prevention of Triglyc-eride Storage. International Journal of Obesity, 36, 207-217. https://doi.org/10.1038/ijo.2011.81 |
| [24] | Argyropoulos, G., Brown, A.M., Willi, S.M., et al. (1998) Effects of Mu-tations in the Human Uncoupling Protein 3 Gene on the Respiratory Quotient and Fat Oxidation in Severe Obesity and Type 2 Diabetes. Journal of Clinical Investigation, 102, 1345-1351. https://doi.org/10.1172/JCI4115 |
| [25] | Jia, J.J., Zhang, X., Ge, C.R. and Jois, M. (2009) The Polymorphisms of UCP2 and UCP3 Genes Associated with Fat Metabo-lism, Obesity and Diabetes. Obesity Reviews, 10, 519-526. https://doi.org/10.1111/j.1467-789X.2009.00569.x |
| [26] | Brown, A.M., Dolan, J.W., Willi, S.M., et al. (1999) En-dogenous Mutations in Human Uncoupling Protein 3 Alter Its Functional Properties. FEBS LettERS, 464, 189-193. https://doi.org/10.1016/S0014-5793(99)01708-1 |
| [27] | Sugimoto, K., Qi, N.R., Kazdová, L., et al. (2006) Telmisar-tan but Not Valsartan Increases Caloric Expenditure and Protects against Weight Gain and Hepatic Steatosis. Hyperten-sion, 47, 1003-1009.
https://doi.org/10.1161/01.HYP.0000215181.60228.f7 |
